Literature DB >> 7845472

Effects of 6-hydroxydopamine on noradrenaline metabolism linked to neuronal uptake1 and extraneuronal uptake1 in dental pulp in vitro.

D A Parker1, V Marino, J Dally, I S de la Lande.   

Abstract

The study was undertaken to determine the relative roles of neuronal and extraneuronal uptake1 in the metabolism of 3H-noradrenaline in human dental pulp. Rabbit dental pulp was used as a reference since it was already known that normetanephrine (NMN) formation in this tissue utilised extraneuronal uptake1. Slices of pulp were preincubated in the absence and presence of 6-hydroxydopamine (1.6 mmol/l, for 10 or 20 min at pH 4.5) and subsequently incubated with 3H-noradrenaline (0.18 mumol/l for 30 min at pH 7.4). The principal metabolites formed were normetanephrine in rabbit pulp and deaminated catechols (dihydroxymandelic acid and dihydroxyphenylglycol) in human pulp. In both tissues 6-hydroxydopamine strongly inhibited formation of the deaminated catechols, but was without effect on normetanephrine formation. It is concluded that: i) in vitro 6-hydroxydopamine does not influence the metabolic process which is dependent on extraneuronal uptake1, namely normetanephrine formation in rabbit dental pulp, and ii) the deaminated catechols are largely neuronal in origin in human pulp. Attention is drawn to an unusual feature of the neuronal metabolism in human pulp, namely the appearance of dihydroxymandelic acid as the principal metabolite.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7845472     DOI: 10.1007/bf00178950

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

2.  Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons.

Authors:  G Jonsson; C Sachs
Journal:  Eur J Pharmacol       Date:  1970-02       Impact factor: 4.432

3.  Uptake and accumulation of 3 H-6-hydroxydopamine in adrenergic nerves.

Authors:  G Jonsson; C Sachs
Journal:  Eur J Pharmacol       Date:  1971-09       Impact factor: 4.432

4.  The role of monoamine oxidase in the metabolism of exogenous noradrenaline by the human saphenous vein.

Authors:  D Branco; M Caramona; D Araújo; W Osswald
Journal:  Fundam Clin Pharmacol       Date:  1992       Impact factor: 2.748

5.  In vitro denervation of the portal vein and caudal artery of the rat.

Authors:  O Aprigliano; K Hermsmeyer
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

6.  Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.

Authors:  D Branco; M Caramona; F Martel; J A de Almeida; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

7.  Vascular uptake of catecholamines in perfused lungs of the rat occurs by the same process as Uptake1 in noradrenergic neurones.

Authors:  L J Bryan-Lluka; N N Westwood; S R O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

8.  Extraneuronal uptake of noradrenaline in rabbit dental pulp: evidence of identity with uptake1.

Authors:  V Marino; I S de la Lande; D A Parker; J Dally; S Wing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

9.  Cocaine-sensitive O-methylation of noradrenaline in dental pulp of the rabbit: comparison with the rabbit ear artery.

Authors:  D A Parker; I S de la Lande; C Proctor; V Marino; N X Lam; I Parker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

10.  The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.

Authors:  H Russ; E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.